Product: Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Reason for recall: Failed Impurities/Degradation Specifications
Recall initiated: 20210903
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated